Sorry I would not know that (lowest cost). - swThanks anyway.As I've mentioned before, I've exited the pharma sector because it had a great run, and I had lotsa profits to harvest. I'm distinctly underweight pharma at the moment, except for TEVA and I'm comfortable with that.Having said all that, I still want pharma in my portfolio. I'm looking several years down the road and pondercating which companies may serve as decent investments. I've been a big fan of SNY, but I can't believe the strong move higher in the Eurozone markets is sustainable. I'll definitely be buying SNY if there's a major "correction."I'll be researching other candidates in coming months. NVO is gonna be vetted big time.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra